Ekso Bionics Inc. (EKSO)
| Bid | 0.42 |
| Market Cap | 12.71M |
| Revenue (ttm) | 17.93M |
| Net Income (ttm) | -11.33M |
| EPS (ttm) | -0.56 |
| PE Ratio (ttm) | -0.78 |
| Forward PE | -4.17 |
| Analyst | Buy |
| Ask | 0.45 |
| Volume | 134,505 |
| Avg. Volume (20D) | 223,093 |
| Open | 0.42 |
| Previous Close | 0.42 |
| Day's Range | 0.40 - 0.45 |
| 52-Week Range | 0.34 - 1.53 |
| Beta | 1.33 |
About EKSO
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices t...
Analyst Forecast
According to 2 analyst ratings, the average rating for EKSO stock is "Buy." The 12-month stock price forecast is $5, which is an increase of 1041.55% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · seekingalpha.com
Ekso Bionics Holdings, Inc. (EKSO) Q4 2024 Earnings Call TranscriptEkso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Company Participants Stephen Kilmer - IR Jerome Wong - Chief Financial Officer Scott Davis - Chief ...